http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.jpg 144 PALO ALTO, Calif. & OSAKA, Aug 05, 2010 -- Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceutical Company Limited (TSE:4502), today announced that the companies have decided on a preliminary... http://pharmalicensing.com/redirs/news_rss//public/news/view/530690/0/5/affymax-and-takeda-announce-preliminary-u-s-registration-strategy-for-investigational-drug-hematide-tm-peginesatide-to-treat-anemia-in-chronic-renal-failure http://pharmalicensing.com/redirs/news_rss//public/news/view/530690/0/5/affymax-and-takeda-announce-preliminary-u-s-registration-strategy-for-investigational-drug-hematide-tm-peginesatide-to-treat-anemia-in-chronic-renal-failure